Pharma Investments B.V.

Location:

Project number:

37597

Business sector:

Manufacturing and Services

Notice type:

Private

Environmental category:

C

Approval date:

03 Dec 2007

Status:

Completed

PSD disclosed:

02 Nov 2007

Project Description

The proposed project will consist of an equity of EUR 15 million to Pharma Investments B.V. The proposed project will support the current operations and future expansion plans of PIBV in the CEE area with the target to create a strong regional pharmaceuticals retail network. PIBV is a subsidiary of Milestone Group Plc, an Icelandic private investment company. The investment programme of EUR 55 million will focus on building a regional pharma network of at least 500 pharmacies with a recognised brand name both through acquisitions and organic growth.

Transition Impact

The main transition impact of the project will derive from the demonstration effect of a successful regional expansion by an experienced foreign investor throughout the CEE countries and the setting of standards of corporate governance and business conduct at the investee company level. In addition, the project will increase competition in the sector through introduction of a wide range of new product choices and additional services, as well as competitive prices to the final customers.

The Client

Pharma Investments B.V., a subsidiary of Milestone Group Plc.

EBRD Finance

EUR 15 million equity.

Project Cost

EUR 55 million.

Environmental Impact

Screened C/1. The development and operation of retail pharmacy stores and wholesale outlets will have limited environmental, health, safety and labour (EHSL) impacts. The Company's approach to EHSL management has been assessed during due diligence and has been found to be adequate. Provisions covering EHSL due diligence procedures and EU standards will be included in the legal agreements. The Company will be required to provide the Bank with an annual environmental report on EHSL matters

Technical Cooperation

None.

Company Contact

Fjolvar Darri Rafnsson, MANAGING DIRECTOR
Pharma Investment B.V.
Drvinje 36
10 000 Zagreb, Croatia

TEL +385 1 3665 093
FAX +385 1 3665 776

E-MAIL: darri@milestone.is

 

Business opportunities

For business opportunities or procurement, contact the client company.

For state-sector projects, visit EBRD Procurement: Tel: +44 20 7338 6794
Email: procurement@ebrd.com

General enquiries

EBRD project enquiries not related to procurement:
Tel: +44 20 7338 7168
Email: projectenquiries@ebrd.com

Public Information Policy (PIP)

The PIP sets out how the EBRD discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations. Please visit the Public Information Policy page below to find out how to request a Public Sector Board Report.
Text of the PIP

Share this page: